This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


AlloCure, Inc.

Drug Names(s): AC-607, NG-0711

Description: AC607 is a novel biologic therapy composed of allogeneic adult bone marrow-derived mesenchymal stem cells (MSC). AC607 avoids recognition by the immune system, does not require donor matching, and is genetically stable.

AC607 is given as an intra-aortic infusion.

AC607 News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug